172 related articles for article (PubMed ID: 9058107)
21. Association of antiphospholipid antibodies with active digital ulceration in systemic sclerosis.
Martin M; Martinez C; Arnaud L; Weber JC; Poindron V; Blaison G; Kieffer P; Bonnotte B; Berthier S; Wahl D; Maurier F; Pennaforte JL; Bielefeld P; Magy-Bertrand N; Devilliers H; Martin T
RMD Open; 2019; 5(2):e001012. PubMed ID: 31673412
[No Abstract] [Full Text] [Related]
22. Systemic Sclerosis with Focus on Scleroderma Renal Crisis.
Pasha F; Abazari S; Bikarannejad P; Zabolian A
Iran J Kidney Dis; 2019 May; 13(3):207-210. PubMed ID: 31209194
[TBL] [Abstract][Full Text] [Related]
23. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
24. [Scleroderma and Raynaud's phenomenon: current pathogenetic interpretations and clinico-therapeutic trends].
Zelli GP; Cannata P
Ann Ital Chir; 1981; 53(3):337-43. PubMed ID: 7337317
[No Abstract] [Full Text] [Related]
25. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
Clements PJ
Curr Opin Rheumatol; 1993 Nov; 5(6):749-52. PubMed ID: 8117537
[No Abstract] [Full Text] [Related]
26. Limited cutaneous systemic sclerosis: report of one case.
Lin MC; Fu LS; Huang KY; Tsen CF; Liou JM; Chi CS
Acta Paediatr Taiwan; 2001; 42(4):248-51. PubMed ID: 11550416
[TBL] [Abstract][Full Text] [Related]
27. Raynaud's phenomenon in limited cutaneous systemic sclerosis.
Bonnecaze AK
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26715139
[No Abstract] [Full Text] [Related]
28. [Clinical and capillaroscopic regression of CD30 anaplastic lymphoma associated with limited cutaneous systemic sclerosis following autologous bone marrow transplantation].
Bellis R; Francès C; Barète S; Senet P
Ann Dermatol Venereol; 2014; 141(6-7):446-51. PubMed ID: 24951144
[TBL] [Abstract][Full Text] [Related]
29. Systemic sclerosis: another rheumatic disease associated with hepatitis C virus infection.
Abu-Shakra M; Sukenik S; Buskila D
Clin Rheumatol; 2000; 19(5):378-80. PubMed ID: 11055827
[TBL] [Abstract][Full Text] [Related]
30. [How to recognize scleroderma].
Francès C; Ayoub N; Barete S
Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
[TBL] [Abstract][Full Text] [Related]
31. Raynaud's phenomenon of the tongue.
Grémain V; Richard L; Langlois V; Marie I
Joint Bone Spine; 2017 Mar; 84(2):231. PubMed ID: 27269655
[No Abstract] [Full Text] [Related]
32. The prognosis of systemic sclerosis.
Rowell NR
Br J Dermatol; 1976 Jul; 95(1):57-60. PubMed ID: 952740
[TBL] [Abstract][Full Text] [Related]
33. Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon.
Istok R; Czirják L; Lukác J; Stancíková M; Rovenský J
Rheumatology (Oxford); 2001 Feb; 40(2):140-6. PubMed ID: 11257149
[TBL] [Abstract][Full Text] [Related]
34. [Raynaud's syndrome--main symptom of progressive systemic sclerosis (sclerodermia)].
Krull P; Alexander K; Fabel H; Ostertag H; Wagner HH; Deicher H
Med Klin; 1972 Mar; 67(10):332-7. PubMed ID: 5022240
[No Abstract] [Full Text] [Related]
35. [A complication of coronary angiography in a female patient with systemic sclerosis].
Dogan K; Bakx R; Klemm PL
Ned Tijdschr Geneeskd; 2011; 155():A2704. PubMed ID: 21291581
[TBL] [Abstract][Full Text] [Related]
36. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
Gore J; Silver R
Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
[No Abstract] [Full Text] [Related]
37. Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review.
García de la Peña Lefebvre P; Nishishinya MB; Pereda CA; Loza E; Sifuentes Giraldo WA; Román Ivorra JA; Carreira P; Rúa-Figueroa I; Pego-Reigosa JM; Muñoz-Fernández S
Rheumatol Int; 2015 Sep; 35(9):1447-59. PubMed ID: 25824427
[TBL] [Abstract][Full Text] [Related]
38. Scleroderma and Raynaud's phenomenon.
BARNETT AJ
Clin Rep; 1959; 9():33-74. PubMed ID: 13796900
[No Abstract] [Full Text] [Related]
39. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of digital ulcers in a scleroderma patient with continuous bilateral thoracic sympathetic block.
Han KR; Kim C; Park EJ
Pain Physician; 2008 Jan; 11(1):91-6. PubMed ID: 18196175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
